Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements

Stefano Indraccolo, Sonia Minuzzo, Laura Nicoletti, Elisabetta Cretella, Martin Simon, Georg Papakonstantinou, Rüdiger Hehlmann, Marta Mion, Roberta Bertorelle, Jelena Roganovic, Luigi Chieco-Bianchi

Research output: Contribution to journalArticle

Abstract

As mice carrying mutations of the DNA mismatch repair genes MSH2 and MSH6 often develop lymphoid neoplasms, we addressed the prevalence of the replication error (RER+) phenotype, a manifestation of an underlying defect of DNA mismatch repair genes, in human lymphoid tumors. We compared microsatellite instability (MSI) at 10 loci in 37 lymphoid tumors, including 16 acute lymphoid leukemias (ALL) and 21 non-Hodgkin's lymphomas (NHL), and in 29 acute myeloid leukemias (AML). Significant differences in MSI prevalence between AMLs and ALLs emerged, and MSI occurrence was more frequent in the NHLs versus AMLs. Indeed, only 3 of 29 (10%) AMLs exhibited MSI, thus confirming its paucity in myeloid tumors, while 10 of 37 (27%) lymphoid tumors, 6 ALLs and 4 NHLs, disclosed an RER+ phenotype. In 1 ALL patient, the same molecular alterations were observed in correspondence with a relapse, but were not detected during remission over a 14-month follow-up; in another ALL patient, findings correlated with impending clinical relapse. These results suggest that the study of MSI in lymphoid tumors might provide a useful molecular tool to monitor disease progression in a subset of ALLs. To correlate MSI with other known genetic abnormalities, we investigated the status of the proto-oncogene, bcl-2, in the lymphoma patients and found that 4 of 4 NHL patients with MSI carried bcl-2 rearrangements, thus linking genomic instability to enhanced cell survival in NHL; moreover, no p53 mutations were found in these patients. Finally, we addressed the putative cause of MSI in hematopoietic tumors by searching for both mutations and deletions affecting DNA repair genes. A limited genetic analysis did not show any tumor-specific mutation in MLH1 exons 9 and 16 and in MSH2 exons 5 and 13. However, loss of heterozygosity (LOH) of markers closely linked to mismatch repair genes MLH1, MSH2, and PMS2 was demonstrated in 4 of 6 ALLs and 1 of 3 AMLs with MSI. These observations indicate that chromosomal deletions might represent a mechanism of inactivation of DNA repair genes in acute leukemia.

Original languageEnglish
Pages (from-to)2424-2432
Number of pages9
JournalBlood
Volume94
Issue number7
Publication statusPublished - Oct 1 1999

Fingerprint

bcl-2 Genes
Microsatellite Instability
Hematologic Neoplasms
DNA Repair
Microsatellite Repeats
Repair
Genes
Phenotype
Tumors
DNA
DNA Mismatch Repair
Neoplasms
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Non-Hodgkin's Lymphoma
Mutation
Exons
Recurrence
Proto-Oncogenes
Sequence Deletion
Genomic Instability

ASJC Scopus subject areas

  • Hematology

Cite this

Indraccolo, S., Minuzzo, S., Nicoletti, L., Cretella, E., Simon, M., Papakonstantinou, G., ... Chieco-Bianchi, L. (1999). Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements. Blood, 94(7), 2424-2432.

Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements. / Indraccolo, Stefano; Minuzzo, Sonia; Nicoletti, Laura; Cretella, Elisabetta; Simon, Martin; Papakonstantinou, Georg; Hehlmann, Rüdiger; Mion, Marta; Bertorelle, Roberta; Roganovic, Jelena; Chieco-Bianchi, Luigi.

In: Blood, Vol. 94, No. 7, 01.10.1999, p. 2424-2432.

Research output: Contribution to journalArticle

Indraccolo, S, Minuzzo, S, Nicoletti, L, Cretella, E, Simon, M, Papakonstantinou, G, Hehlmann, R, Mion, M, Bertorelle, R, Roganovic, J & Chieco-Bianchi, L 1999, 'Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements', Blood, vol. 94, no. 7, pp. 2424-2432.
Indraccolo S, Minuzzo S, Nicoletti L, Cretella E, Simon M, Papakonstantinou G et al. Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements. Blood. 1999 Oct 1;94(7):2424-2432.
Indraccolo, Stefano ; Minuzzo, Sonia ; Nicoletti, Laura ; Cretella, Elisabetta ; Simon, Martin ; Papakonstantinou, Georg ; Hehlmann, Rüdiger ; Mion, Marta ; Bertorelle, Roberta ; Roganovic, Jelena ; Chieco-Bianchi, Luigi. / Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements. In: Blood. 1999 ; Vol. 94, No. 7. pp. 2424-2432.
@article{8e68a265005e418792bd65af12494ff6,
title = "Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements",
abstract = "As mice carrying mutations of the DNA mismatch repair genes MSH2 and MSH6 often develop lymphoid neoplasms, we addressed the prevalence of the replication error (RER+) phenotype, a manifestation of an underlying defect of DNA mismatch repair genes, in human lymphoid tumors. We compared microsatellite instability (MSI) at 10 loci in 37 lymphoid tumors, including 16 acute lymphoid leukemias (ALL) and 21 non-Hodgkin's lymphomas (NHL), and in 29 acute myeloid leukemias (AML). Significant differences in MSI prevalence between AMLs and ALLs emerged, and MSI occurrence was more frequent in the NHLs versus AMLs. Indeed, only 3 of 29 (10{\%}) AMLs exhibited MSI, thus confirming its paucity in myeloid tumors, while 10 of 37 (27{\%}) lymphoid tumors, 6 ALLs and 4 NHLs, disclosed an RER+ phenotype. In 1 ALL patient, the same molecular alterations were observed in correspondence with a relapse, but were not detected during remission over a 14-month follow-up; in another ALL patient, findings correlated with impending clinical relapse. These results suggest that the study of MSI in lymphoid tumors might provide a useful molecular tool to monitor disease progression in a subset of ALLs. To correlate MSI with other known genetic abnormalities, we investigated the status of the proto-oncogene, bcl-2, in the lymphoma patients and found that 4 of 4 NHL patients with MSI carried bcl-2 rearrangements, thus linking genomic instability to enhanced cell survival in NHL; moreover, no p53 mutations were found in these patients. Finally, we addressed the putative cause of MSI in hematopoietic tumors by searching for both mutations and deletions affecting DNA repair genes. A limited genetic analysis did not show any tumor-specific mutation in MLH1 exons 9 and 16 and in MSH2 exons 5 and 13. However, loss of heterozygosity (LOH) of markers closely linked to mismatch repair genes MLH1, MSH2, and PMS2 was demonstrated in 4 of 6 ALLs and 1 of 3 AMLs with MSI. These observations indicate that chromosomal deletions might represent a mechanism of inactivation of DNA repair genes in acute leukemia.",
author = "Stefano Indraccolo and Sonia Minuzzo and Laura Nicoletti and Elisabetta Cretella and Martin Simon and Georg Papakonstantinou and R{\"u}diger Hehlmann and Marta Mion and Roberta Bertorelle and Jelena Roganovic and Luigi Chieco-Bianchi",
year = "1999",
month = "10",
day = "1",
language = "English",
volume = "94",
pages = "2424--2432",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Mutator phenotype in human hematopoietic neoplasms and its association with deletions disabling DNA repair genes and bcl-2 rearrangements

AU - Indraccolo, Stefano

AU - Minuzzo, Sonia

AU - Nicoletti, Laura

AU - Cretella, Elisabetta

AU - Simon, Martin

AU - Papakonstantinou, Georg

AU - Hehlmann, Rüdiger

AU - Mion, Marta

AU - Bertorelle, Roberta

AU - Roganovic, Jelena

AU - Chieco-Bianchi, Luigi

PY - 1999/10/1

Y1 - 1999/10/1

N2 - As mice carrying mutations of the DNA mismatch repair genes MSH2 and MSH6 often develop lymphoid neoplasms, we addressed the prevalence of the replication error (RER+) phenotype, a manifestation of an underlying defect of DNA mismatch repair genes, in human lymphoid tumors. We compared microsatellite instability (MSI) at 10 loci in 37 lymphoid tumors, including 16 acute lymphoid leukemias (ALL) and 21 non-Hodgkin's lymphomas (NHL), and in 29 acute myeloid leukemias (AML). Significant differences in MSI prevalence between AMLs and ALLs emerged, and MSI occurrence was more frequent in the NHLs versus AMLs. Indeed, only 3 of 29 (10%) AMLs exhibited MSI, thus confirming its paucity in myeloid tumors, while 10 of 37 (27%) lymphoid tumors, 6 ALLs and 4 NHLs, disclosed an RER+ phenotype. In 1 ALL patient, the same molecular alterations were observed in correspondence with a relapse, but were not detected during remission over a 14-month follow-up; in another ALL patient, findings correlated with impending clinical relapse. These results suggest that the study of MSI in lymphoid tumors might provide a useful molecular tool to monitor disease progression in a subset of ALLs. To correlate MSI with other known genetic abnormalities, we investigated the status of the proto-oncogene, bcl-2, in the lymphoma patients and found that 4 of 4 NHL patients with MSI carried bcl-2 rearrangements, thus linking genomic instability to enhanced cell survival in NHL; moreover, no p53 mutations were found in these patients. Finally, we addressed the putative cause of MSI in hematopoietic tumors by searching for both mutations and deletions affecting DNA repair genes. A limited genetic analysis did not show any tumor-specific mutation in MLH1 exons 9 and 16 and in MSH2 exons 5 and 13. However, loss of heterozygosity (LOH) of markers closely linked to mismatch repair genes MLH1, MSH2, and PMS2 was demonstrated in 4 of 6 ALLs and 1 of 3 AMLs with MSI. These observations indicate that chromosomal deletions might represent a mechanism of inactivation of DNA repair genes in acute leukemia.

AB - As mice carrying mutations of the DNA mismatch repair genes MSH2 and MSH6 often develop lymphoid neoplasms, we addressed the prevalence of the replication error (RER+) phenotype, a manifestation of an underlying defect of DNA mismatch repair genes, in human lymphoid tumors. We compared microsatellite instability (MSI) at 10 loci in 37 lymphoid tumors, including 16 acute lymphoid leukemias (ALL) and 21 non-Hodgkin's lymphomas (NHL), and in 29 acute myeloid leukemias (AML). Significant differences in MSI prevalence between AMLs and ALLs emerged, and MSI occurrence was more frequent in the NHLs versus AMLs. Indeed, only 3 of 29 (10%) AMLs exhibited MSI, thus confirming its paucity in myeloid tumors, while 10 of 37 (27%) lymphoid tumors, 6 ALLs and 4 NHLs, disclosed an RER+ phenotype. In 1 ALL patient, the same molecular alterations were observed in correspondence with a relapse, but were not detected during remission over a 14-month follow-up; in another ALL patient, findings correlated with impending clinical relapse. These results suggest that the study of MSI in lymphoid tumors might provide a useful molecular tool to monitor disease progression in a subset of ALLs. To correlate MSI with other known genetic abnormalities, we investigated the status of the proto-oncogene, bcl-2, in the lymphoma patients and found that 4 of 4 NHL patients with MSI carried bcl-2 rearrangements, thus linking genomic instability to enhanced cell survival in NHL; moreover, no p53 mutations were found in these patients. Finally, we addressed the putative cause of MSI in hematopoietic tumors by searching for both mutations and deletions affecting DNA repair genes. A limited genetic analysis did not show any tumor-specific mutation in MLH1 exons 9 and 16 and in MSH2 exons 5 and 13. However, loss of heterozygosity (LOH) of markers closely linked to mismatch repair genes MLH1, MSH2, and PMS2 was demonstrated in 4 of 6 ALLs and 1 of 3 AMLs with MSI. These observations indicate that chromosomal deletions might represent a mechanism of inactivation of DNA repair genes in acute leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0033215386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033215386&partnerID=8YFLogxK

M3 - Article

C2 - 10498615

AN - SCOPUS:0033215386

VL - 94

SP - 2424

EP - 2432

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -